Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2

NCT01925118 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Ineffectiveness

Conditions

Metastatic Malignant Melanoma and Renal Cell Carcinoma

Interventions

BIOLOGICAL: Irradiated donor lymphocyte infusion

Sponsor

Seoul National University Hospital